Form 4: Zimmer Biomet Exec VP Suketu Upadhyay Reports Stock Transactions

Executive VP and CFO of Zimmer Biomet, Suketu Upadhyay, reports acquisition and disposal of common stock and restricted stock units.

Summary

• Suketu Upadhyay, Executive VP and CFO of Zimmer Biomet Holdings, Inc., filed a Form 4 detailing changes in beneficial ownership.
• On February 18, 2025, Upadhyay acquired 21,622 shares of common stock through the vesting of restricted stock units (RSUs).
• Also on February 18, 2025, Upadhyay disposed of 8,155 shares to satisfy tax withholding obligations related to the RSU vesting at a price of $101.
• Upadhyay also acquired 87 shares under the Employee Stock Purchase Plan through February 18, 2025.
• Following these transactions, Upadhyay beneficially owns 51,454 shares of common stock directly.
• Upadhyay also owns 21,622 restricted stock units.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing reflects standard executive compensation practices. The vesting of RSUs suggests positive performance, but the subsequent tax-related disposal is a neutral event.

Positives

• The vesting of RSUs indicates that performance conditions were met, suggesting positive performance during the 2022-2024 period.
• Acquisition of shares through the Employee Stock Purchase Plan shows confidence in the company's future.

Negatives

• The disposal of shares to cover tax obligations, while standard, reduces the overall increase in Upadhyay's holdings.

Industry Context

Form 4 filings are a routine part of executive compensation and provide transparency into the trading activities of company insiders. This filing is typical for executives receiving and managing equity-based compensation.

Comparison to Industry Standards

• Executive compensation packages often include RSUs as a way to align executive interests with shareholder value.
• The vesting of RSUs based on performance metrics is a common practice in the industry.
• Tax withholding obligations upon vesting of RSUs are standard and result in the disposal of a portion of the shares.

Stakeholder Impact

• The vesting of RSUs aligns executive compensation with company performance, potentially benefiting shareholders.
• The transactions have a minimal direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Zimmer Biomet, Suketu Upadhyay, Form 4, Beneficial Ownership, Restricted Stock Units, RSUs, Stock Transactions, Executive Compensation